WHO ICTRP trial

AN OPEN LABEL STUDY OF ORAL DESMOPRESSIN IN CHILDREN AGED 5 TO 15 YEARS WITH…

EUCTR2004-001735-37-SI · EU Clinical Trials Register · Authorised

Key facts

Trial ID EUCTR2004-001735-37-SI
Public title AN OPEN LABEL STUDY OF ORAL DESMOPRESSIN IN CHILDREN AGED 5 TO 15 YEARS WITH PRIMARY NOCTURAL ENURESIS
Scientific title AN OPEN LABEL STUDY OF ORAL DESMOPRESSIN IN CHILDREN AGED 5 TO 15 YEARS WITH PRIMARY NOCTURAL ENURESIS
Primary sponsor FERRING ARZNEIMITTEL Ges.m.b.h. CEE AUSTRIA
Registry EU Clinical Trials Register
Recruitment status Authorised
Study type Interventional clinical trial of medicinal product
Countries Slovenia
Conditions Primary noctural enuresis
Interventions Trade Name: MINIRIN Product Name: MINIRIN Pharmaceutical Form: Tablet INN or Proposed INN: desmopressin Concentration unit: mg milligram(s) Concentration type: range Concentration number: 0,2-0,4
Registration date Jan 30, 2006
Target size 110
Secondary IDs FL-CR001
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations